Sec Form 4/A Filing - DELEAGE JEAN @ XCYTE THERAPIES INC - 2004-03-19

FORM 4/A Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person DELEAGE JEAN 2. Issuer Name and Ticker or Trading Symbol XCYTE THERAPIES INC [ XCYT] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) ONE EMBARCADERO CENTER, SUITE 4050 3. Date of Earliest Transaction (MM/DD/YY) 03/19/2004 (Street) SAN FRANCISCO, CA94111 4. If Amendment, Date Original Filed (MM/DD/YY) 03/24/2004 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/19/2004 P 125,000 A $ 8 0 I See Footnote ( 1 ) Common Stock 03/19/2004 C 1,017,400 A $ 0 1,142,400 I See Footnote ( 1 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Director Stock Option $ 0 ( 2 ) 03/19/2004 C 0 ( 3 ) 03/19/2004 Common Stock 5,455 $ 0 5,455 D ( 4 ) Series A Convertible Preferred Stock $ 0 ( 2 ) 03/19/2004 C 1,894,737 ( 3 ) 03/19/2004 Common Stock 1,894,737 $ 5.225 0 I See Footnote ( 1 ) Series B Convertible Preferred Stock $ 0 ( 2 ) 03/19/2004 C 805,281 ( 3 ) 03/19/2004 Common Stock 805,281 $ 6.05 0 I See Footnote ( 1 ) Series C Convertible Preferred Stock $ 0 ( 2 ) 03/19/2004 C 971,331 ( 3 ) 03/19/2004 Common Stock 971,331 $ 9.185 0 I See Footnote ( 1 ) Series D Convertible Preferred Stock $ 0 ( 2 ) 03/19/2004 C 584,547 ( 3 ) 03/19/2004 Common Stock 584,547 $ 15.29 0 I See Footnote ( 1 ) Series E Convertible Preferred Stock $ 0 ( 2 ) 03/19/2004 C 359,712 ( 3 ) 03/19/2004 Common Stock 359,712 $ 15.29 0 I See Footnote ( 1 ) Common Stock Warrants (right to buy) $ 0 ( 2 ) 03/19/2004 X 261,312 ( 3 ) 03/19/2004 Common Stock 261,312 $ 0.055 0 I See Footnote ( 1 ) Preferred Stock Warrants (right to buy) $ 0 ( 2 ) 03/19/2004 X 261,312 ( 3 ) 03/19/2004 Common Stock 261,312 $ 0.055 0 I See Footnote ( 1 ) 6% Convertible Promissory Note $ 0 ( 2 ) 03/19/2004 X 261,312 ( 3 ) 03/19/2004 Common Stock 261,312 $ 9.625 0 I See Footnote ( 1 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other DELEAGE JEAN ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO, CA94111 X NOHRA GUY P ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO, CA94111 See Footnote #1 ALTA CALIFORNIA PARTNERS LP ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO, CA94111 No longer 10% holder ALTA EMBARCADERO PARTNERS LLC ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO, CA94111 No longer 10% holder GRUENER GARRETT ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO, CA94111 See Footnote #1 ALTA CALIFORNIA MANAGEMENT PARTNERS LP ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO, CA94111 No longer 10% holder Signatures /s/ Jean Deleage 03/24/2004 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Alta Partners ("AP") provides investment advisory services to several venture capital funds including, Alta California Partners, L.P. ("ACP") and Embarcadero Partners ,LLC("AEP").The respective general partner and members of ACP & AEP exercise sole voting and investment power with respect to the shares held by such funds. Jean Deleage , Garrett Gruener and Guy Nophra are general partners ("GP") of Alta California Management Partners, LLC (which is the general partner of ACP), and Jean Deleage and Garrett Gruener are members of AEP (collectively known as the "principals"). As GP and members of such funds, they may be deemed to share voting and investment powers over the shares held by such funds. The principles of AP disclaim beneficial ownership of all such shares held by the foregoing funds, except to the extent of their proportionate pecuniary interests therein. ( 2 )1-for-5.5 ( 3 )Immed. ( 4 )Jean Deleage,Director,is a general partner of Alta California Management Partners,LLC(which is the general partner of Alta California Partners, L.P.)("ACP"), and a member of Alta Embarcadero Partners ,LLC("AEP"). As a general partner and member of such funds , he may be deemed to share voting and investment powers over the shares held by such funds He disclaims beneficial ownership of the shares held by ACP & AEP , except to the extent of his proportionate interests therein. Mr.Deleage holds a stock option for 30,000 shares of Common Stock that was granted on 11/15/96.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.